EntryPoint Capital’s Arcutis Biotherapeutics ARQT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-17,774	Closed	-$165K	–	711
2024 Q3	$165K	Buy	17,774 +11,202	+170%	+$104K	0.09%	506
2024 Q2	$61.1K	Buy	+6,572	New	+$61.1K	0.09%	491